Skip to main content
OpenTrials
Completed

NCT Number: NCT06073977

Risk Factors for Pediatric Difficult Supraglottic Airway Placement and Ventilation

This study is designed to observe the occurrence of failure or difficulty during placement of supraglottic airway devices (SGAs) and its associated risk factors in pediatric patients. Despite wide use in pediatric practice, not much is known related to problems during SGA insertion unlike adults. The main information regarding pediatric SGA comes from either small comparative studies or retrospective studies reporting increased risk of failure. Thus the main aim of this prospective, multicentric, observational study is to determine the incidence of "difficult" or "failed" SGA placement in children and clarify the possible risk factors for difficulty.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–12 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Asli Dönmez, Ankara, Turkey (Türkiye)

Loading trial locations.

About this study

Inclusion criteria

  • 1- 12 years old peditatric patients
  • ASA class I- III
  • Scheduled for elective surgery under general anaesthesia, in whom a SGA would be used for airway maintenance
  • Planned surgery under general anesthesia with SGA
  • Patients whose legal guardians provide informed consent

Exclusion criteria

  • Refusal to participate in the study.
  • Inability of patient or parents to understand the study or consent process
  • Orotracheal intubation requirement
  • Pathology of airway, neck, respiratory tract, upper gastrointestinal tract
  • Increased risk of regurgitation or aspiration
  • Emergency surgeries
  • Requirement for intensive care follow-up after the surgery

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1- 12 years old peditatric patients
  • ASA class I- III
  • Planned surgery under general anesthesia with supraglottic airway
  • Patients whose legal guardians provide informed consent

Exclusion criteria

  • Refusal to participate in the study
  • Inability of patient or parents to understand the study or consent process
  • Orotracheal intubation requirement
  • Pathology of airway, neck, respiratory tract, upper gastrointestinal tract
  • Increased risk of regurgitation or aspiration
  • Emergency surgeries
  • Requirement for intensive care follow-up after the surgery

Treatment and study plan

Primary outcomes

  1. The incidence of difficulty in supraglottic airway device(SGA) placement

    Time frame: Immediately after the attempt of insertion and up to the end of the surgery

    Difficulty in placing SGA is defined as follows: SGA insertion that requires more than one attempt,need for a change the size or type of SGA,desatutaion (SpO2<93%), disrupted capnography,high airway pressure (>25 cmH2O of peak pressure)

Secondary outcomes

  1. Risk factors for pediatric difficult SGA placement

    Time frame: At the beginning of anesthesia

    Possible risk factors related with failure and difficulty listed as:experience of the anaesthetist , presence of history of asthma/pneumoniae,presence of craniofascial anomalies, use of neuromuscular blocking agent, type and placement technique of SGA

  2. The incidence of complications related to SGA insertion

    Time frame: Up to 24 hours after surgery

    The incidence of adverse events including laryngospasm, desaturation bronchospasm, stridor, regurgitation bucking, airway trauma and postoperative complications including difficult weaning, cough, stridor, vomiting, dysfagia, dysphonia

Sponsors and collaborators

Lead sponsor

Alper Kilicaslan

Other

Collaborators

  • Alkin Çolak
  • Emre Sertaç Bingül
  • Esra Turunç
  • Faruk Çiçekçi
  • Gaye Aydın
  • Nüzhet Mert Şentürk
  • Sedat Saylan
  • Sibel Seçkin Pehlivan
  • Özlem Sezen
  • Şengül Özmert

Registry information

Official study title

Risk Factors for Pediatric Difficult Supraglottic Airway Placement and Ventilation (PEDSGAP): A Multicentric Prospective Observational Study

Acronym: PEDSGAP

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 10, 2023
Registry last updated
Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.